Your browser doesn't support javascript.
loading
GABAergic modulation of secondary hyperalgesia: A randomized controlled 4-way crossover trial with the α2-subunit preferring GABA positive allosteric modulator, N-desmethyl-clobazam in healthy volunteers.
Matthey, Alain; Daali, Youssef; Curtin, François; Poncet, Antoine; Desmeules, Jules; Besson, Marie.
Afiliación
  • Matthey A; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Daali Y; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Curtin F; Faculty of Medicine, Geneva University, Geneva, Switzerland.
  • Poncet A; Division of Clinical Pharmacology and Toxicology, Multidisciplinary Pain Center, Geneva University Hospitals, Geneva, Switzerland.
  • Desmeules J; Faculty of Medicine, Geneva University, Geneva, Switzerland.
  • Besson M; Division of Clinical Epidemiology, Geneva University Hospitals, Geneva, Switzerland.
Eur J Pain ; 24(6): 1094-1106, 2020 07.
Article en En | MEDLINE | ID: mdl-32171038

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzodiazepinas / Clobazam / Hiperalgesia Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur J Pain Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Benzodiazepinas / Clobazam / Hiperalgesia Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur J Pain Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Suiza